DUBLIN--(BUSINESS WIRE)--The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Postoperative Pain in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.
The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Postoperative Pain from 2017 to 2028 segmented by seven major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Further, according to the publisher, in 2017, it is estimated that the severity-specific incident cases of postoperative pain in France were 1,194,644, 1,439,003 and 828,105 in mild, moderate and severe cases respectively. Additionally, Japan was observed with 12,134,677 incident cases for postoperative pain in 2017.
Key Benefits
- This report will help to develop Business Strategies by understanding the trends shaping and driving the Postoperative Pain market
- Organize sales and marketing efforts by identifying the best opportunities for Postoperative Pain market
- To understand the future market competition in the Postoperative Pain market.
Key Topics Covered:
1. Key Insights
2. Postoperative Pain Market Overview at a Glance
2.1. Market Share (%) Distribution of Postoperative Pain in 2017
2.2. Market Share (%) Distribution of Postoperative Pain in 2028
3. Disease Background and Overview: Postoperative Pain
3.1. Introduction
3.2. Transition from Acute to Chronic Pain
3.2.1. Elective or Planned Procedures
3.2.2. Common Types of Acute Postoperative Pains
3.3. Pathophysiology of Acute Pain
3.3.1. Formation of reflexes in postoperative pain
3.3.2. Negative effects of postoperative pain on various organ systems
3.3.3. Psychological effects of postoperative pain
3.3.4. Late effects of insufficient postoperative analgesia
3.3.5. Chronic postoperative pain
3.4. Factors affecting postoperative pain
3.5. Diagnosis of Postoperative Pain
3.5.1. Medical history, physical examination, and specific evaluation of pain
3.5.2. Measuring pain
3.5.3. Various Grading Scales used for Diagnosis of Acute Pain
3.5.4. Verbal methods of pain assessment
3.5.5. Multidimensional methods of pain assessment
3.5.6. Nonverbal methods of pain assessment
3.6. Diagnostic Algorithm
3.7. Guidelines
3.7.1. Guidelines on the Management of Postoperative Pain
3.7.2. Goals and Elements of the Initial Assessment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total number of Incident cases of Postoperative Pain in the 7MM
5. Epidemiology of Postoperative Pain in the 7MM
5.1. Assumptions and Rationale
5.2. United States
5.2.1. Total number of surgical procedures in the US
5.2.2. Total number of Postoperative Pain Incident cases in the US
5.2.3. Severity-specific Postoperative Pain incident cases in the US
5.3. Germany
5.4. France
5.5. Italy
5.6. Spain
5.7. United Kingdom
5.8. Japan
6. Treatment
6.1.1. Pharmacological Therapies
6.1.2. Multimodal analgesia
6.1.3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
6.1.4. Opioids
6.1.5. Non-opioid analgesics
6.1.6. Procedure-specific analgesia
6.1.7. Regional anesthesia
6.1.8. Non-Pharmacological Methods to Treat Acute Pain
6.1.9. Physical methods
6.1.10. Intravenous Patient-Controlled Analgesia (PCA)
6.1.11. Nerve Blocks
6.1.12. Pediatric Pain Management
6.2. Treatment Algorithm for Acute Postoperative Pain
7. Guidelines for Acute Pain
7.1.1. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy (2017)
7.1.2. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council (2017)
8. Unmet Needs
9. Marketed Drugs
9.1. Marketed Drugs Key-cross Competition
9.2. Zalviso: AcelRx Pharmaceuticals
9.2.1. Product Description
9.2.2. Regulatory Milestones
9.2.3. Other Developmental activities
9.2.4. Clinical Development
9.2.5. Safety and Efficacy
9.2.6. Product Profile
9.3. Maxigesic: AFT Pharmaceuticals
9.4. Dsuvia/Dzuveo (Sufentanil): AcelRx Pharmaceuticals
9.5. Dexketoprofen Tramadol: Menarini Group
10. Emerging Drugs
10.1. Key Cross Competition
10.2. Olinvo (Oliceridine injection or TRV130): Trevena
10.2.1. Product Description
10.2.2. Other Development Activities
10.2.3. Clinical Development
10.2.4. Safety and Efficacy
10.2.5. Product Profile
10.3. HTX-011: Heron Therapeutics
10.4. CR845/Difelikefalin: Cara Therapeutics
10.5. NTM-001: Neumentum Pharmaceuticals
10.6. PF-05089771: Pfizer
11. Postoperative Pain: 7 Major Market Analysis
11.1. Key Findings
11.2. Forecasting Parameters
11.3. Market Size of Postoperative Pain in the 7MM Countries
12. 7MM Market Outlook
12.1. Expected Approval: Emerging Therapies
12.2. United States
12.2.1. Total Market size of Postoperative Pain
12.2.2. Market Size by Therapies
12.3. Germany
12.4. France
12.5. Italy
12.6. Spain
12.7. United Kingdom
12.8. Japan Market Size
13. Market Drivers
14. Market Barriers
15. Appendix
16. Capabilities
For more information about this report visit https://www.researchandmarkets.com/r/73oyor
